V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody

Product Graph
416€ (200 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx431809
tested applications
P-ELISA, WB

Description

VTCN1 Antibody is a Goat Polyclonal antibody against VTCN1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1)
Host
Goat
Reactivity
Human
Recommended Dilution
P-ELISA: 1/16000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Size 1
200 µl
Form
Liquid
Tested Applications
P-ELISA, WB
Buffer
Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
79679, 242122, 295322
NCBI Accession
NP_078902.2
Background
Antibody anti-VTCN1
Status
RUO
Note
Concentration: 0.5 mg/ml -

Descripción

Related Products

EH1214

Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit

Ver Producto
FNab09461

VTCN1 antibody

Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.

Ver Producto
P1973

Recombinant Human VTCN1

Ver Producto